UCB

Few pharmaceuticals players in Europe match the executional depth of UCB. From Brussels, the group manages a workforce of approximately 9k and generates close to $6B in revenue, while steadily widening the gap with regional peers.

Talent density and engineering culture have become a quiet competitive moat, particularly as the sector consolidates around fewer global champions.

“UCB is, in its category, exactly the kind of compounding regional champion the next decade of capital allocation will reward.”

The outlook remains constructive: order books, hiring patterns and capex guidance all point to a multi-year expansion phase.